View Document Preview and Link Open Document File Size: 552,64 KB Share Result on Facebook
City Hilden / Daejeon / Foster City / / Company GE / Furukawa / Eastern Cooperative Oncology Group / Honda / Qiagen / Pearson / Philco / Shimizu / British Journal / / Country Germany / United States / Korea / United Kingdom / South Korea / / Currency pence / / / Event Product Issues / FDA Phase / / Facility Research Institute / National Cancer Institute of Canada / National Cancer Center / National Cancer Institute / / IndustryTerm wild-type vs / treatment of advanced gastric cancer / Treatment of Cancer / enzyme product / / MedicalCondition gastric cancer / metastatic gastroesophageal adenocarcinoma / JE / documented disease / mucinous carcinoma / leukopenia / advanced biliary cancer / Solid Tumors / nausea / thrombocytopenia / J Cancer / metastatic disease / III epithelial ovarian cancer / Global cancer / non-small-cell lung cancer / non-small cell lung cancer / advanced non-small cell lung cancer / esophageal cancer / gastroesophageal adenocarcinoma study / epithelial ovarian cancer / advanced gastric cancer / advanced non-small-cell lung cancer / metastatic biliary cancer / concurrent uncontrolled medical illness / tumor / common cancer / liver metastases / cancer / disease / neutropenia / advanced esophagogastric cancer / tumour / III non-small cell lung cancer / vomiting / metastatic gastric cancer / nonsmall cell lung cancer / recurrent metastatic disease / stable disease / adult-onset glioma / Clin Lung Cancer / metastases / / MedicalTreatment Adjuvant chemotherapy / chemotherapy / intravenous infusion / gastrojejunostomy / combination chemotherapies / cisplatin chemotherapy / adjuvant therapy / / Organization Association of CYP2A6 / Institutional Review Board / Association of an ERCC1 / European Organization for Research and Treatment of Cancer / ERCC1 19442C4A A/A C/A C/C Association / Research Institute / Center for Gastric Cancer / National Cancer Institute of Canada / Prophylactic administration / National Cancer Institute of the United States / / Person Haddad V / Van Glabbeke / Ann Oncol / / Position thermal cycler / messenger / Fisher / Marshall / / Product cisplatin / Kaplan / dexamethasone / paclitaxel / S-1 / fluorouracil / nicotine / ERCC1 / variant alleles / alleles / S / / PublishedMedium Cancer Research / British Journal of Cancer / / Technology Genomics / X-ray / electrophoresis / tomography / genotyping / pharmacokinetics / Pharmacogenetics / chemotherapy / SNP / Genotype / / URL http / SocialTag 
British Journal of Cancer[removed], 1126 – 1134 & 2011 Cancer Research UK All rights reserved 0007 – [removed]www.bjcancer.com CYP2A6 and ERCC1 polymorphisms correlate with efficacy